Kriya Hops

Kriya is a biotechnology company specializing in the discovery and commercialization of therapeutic compounds derived from non-cannabis plant sources. The company is most notable for its Kriya Hops platform, which utilizes a proprietary variety of the hops plant (Humulus lupulus) that naturally produces high levels of CBD and other cannabinoids. This innovation provides a unique, non-cannabis source for endocannabinoid system modulators, marketed under the brand name ImmunAg. Kriya's products are designed to address a range of health concerns, including chronic inflammation, pain management, and immune system support. By leveraging agricultural biotechnology, the company aims to provide standardized, plant-based alternatives to traditional pharmaceutical and cannabis-derived treatments. Kriya operates at the intersection of nutraceuticals and biotechnology, focusing on the metabolic and physiological benefits of botanical extracts.